These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 6469205)

  • 1. Radiological and ultrasonographic investigations with respect to patient selection and monitoring for chemical gallstone dissolution.
    Leuschner M; Leuschner U; Strohm WD; Trüber E; Fuchs H; Classen M
    Hepatogastroenterology; 1984 Jun; 31(3):140-3. PubMed ID: 6469205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral dissolution therapy for cholelithiasis: mix and match.
    Phillips RS; Barkin JS
    Am J Gastroenterol; 1990 Nov; 85(11):1532-3. PubMed ID: 2239886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Recurrent gallstones and possibilities for treatment after successful gallstone dissolution].
    Tudyka J; Wechsler JG; Kratzer W; Ernst S; Mack C; Janowitz P; Ditschuneit H
    Med Klin (Munich); 1991 Nov; 86(11):585-8, 606. PubMed ID: 1770899
    [No Abstract]   [Full Text] [Related]  

  • 4. [Gallstone dissolution].
    Leuschner U
    Internist (Berl); 1980 Oct; 21(10):607-16. PubMed ID: 7005153
    [No Abstract]   [Full Text] [Related]  

  • 5. [Computed X-ray tomography in predicting the efficacy of oral cholelithiasis with bile acids].
    Fu XB
    Zhonghua Yi Xue Za Zhi; 1993 Feb; 73(2):81-4, 126. PubMed ID: 8391902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative efficacy and side effects of ursodeoxycholic and chenodeoxycholic acids in dissolving gallstones. A double-blind controlled study.
    Fromm H; Roat JW; Gonzalez V; Sarva RP; Farivar S
    Gastroenterology; 1983 Dec; 85(6):1257-64. PubMed ID: 6354826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acquired gallstone opacification during cholelitholytic treatment with chenodeoxyholic, ursodeoxycholic, and tauroursodeoxycholic acids.
    Bazzoli F; Festi D; Mazzella G; Frabboni R; Zagari RM; Fossi S; Pozzato P; Sottili S; Simoni P; Roda A
    Am J Gastroenterol; 1995 Jun; 90(6):978-81. PubMed ID: 7771434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gall-stone dissolution treatment using cholelitholytic bile acids: experience with 24 patients.
    van Erpecum KJ; van Berge Henegouwen GP; van der Werf SD
    Neth J Med; 1989 Feb; 34(1-2):3-9. PubMed ID: 2644556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of gallstones with chenodeoxy-and ursodeoxycholic acid; the influence of presence or absence of hyperlipidemia on gallstone dissolution.
    Kajiyama G; Maruhashi A; Mizuno T; Yamada K; Kawamoto T; Fujiyama M; Kubota S; Sasaki H; Oyamada K; Nakao S; Miyoshi A
    Hiroshima J Med Sci; 1979 Jun; 28(2):67-71. PubMed ID: 478985
    [No Abstract]   [Full Text] [Related]  

  • 10. [Combined therapy with chenodeoxycholic acid and ursodeoxycholic acid of radiolucent biliary lithiasis].
    Pérez Aguilar F; Breto M; del Val A; Berenguer J
    An Med Interna; 1989 Mar; 6(3):119-24. PubMed ID: 2491184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Importance of cholegraphy for indicating litholysis].
    Wolpers C
    Rofo; 1982 Oct; 137(4):444-50. PubMed ID: 6216183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Computed tomography in predicting the efficacy of oral cholelitholysis with bile acids.
    Fu XB; Liu JY; Liu GN; Shao XM; Zhou XS
    Chin Med J (Engl); 1993 Oct; 106(10):734-8. PubMed ID: 8033604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of ursodeoxycholic acid for dissolution of gallstone fragments: comparison with the combination of ursodeoxycholic acid and chenodeoxycholic acid.
    Sackmann M; Pauletzki J; Aydemir U; Holl J; Sauerbruch T; Hasford J; Paumgartner G
    Hepatology; 1991 Dec; 14(6):1136-41. PubMed ID: 1959863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Final outcome of ursodeoxycholic acid treatment in 126 patients with radiolucent gallstones.
    Gleeson D; Ruppin DC; Saunders A; Murphy GM; Dowling RH
    Q J Med; 1990 Jul; 76(279):711-29. PubMed ID: 2217675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes of bile acid and lipid composition in blood and bile in the clinical course after the initiation of cheno- and ursodeoxycholic acid therapy in patients with cholesterol gallstones.
    Iwamura K
    Tokai J Exp Clin Med; 1982 Nov; 7(6):671-83. PubMed ID: 7184199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical studies on cheno- and ursodeoxycholic acid treatment for gallstone dissolution.
    Iwamura K
    Hepatogastroenterology; 1980 Feb; 27(1):26-34. PubMed ID: 7203354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetics of cholesterol gallstone dissolution by glycocheno-, glyco-ursodeoxycholic acid, and mixtures of both in vitro.
    Raedsch R; Stiehl A; Götz R; Walker S; Kommerell B
    Z Gastroenterol; 1981 Apr; 19(4):159-63. PubMed ID: 7234028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome of chenodeoxycholic acid (CDCA) treatment in 125 patients with radiolucent gallstones. Factors influencing efficacy, withdrawal, symptoms and side effects and post-dissolution recurrence.
    Maton PN; Iser JH; Reuben A; Saxton HM; Murphy GM; Dowling RH
    Medicine (Baltimore); 1982 Mar; 61(2):86-97. PubMed ID: 7062856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Indications and limitations of drug therapy in gallstone].
    Onuki K; Ichida F
    Nihon Rinsho; 1984 Jul; 42(7):1690-5. PubMed ID: 6492412
    [No Abstract]   [Full Text] [Related]  

  • 20. [Indications for the medical gallstone dissolution].
    Weis HJ
    Fortschr Med; 1980 Sep; 98(33):1235-9. PubMed ID: 6780436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.